Nanotechnology researchers develop color-changing stress sensor

It is helpful - even life-saving - to have a warning sign before a structural system fails, but, when the system is only a few nanometers in size, having a sign that's easy to read is a challenge. Now, thanks to a clever bit of molecular design by University of Pennsylvania and Duke University bioengineers and chemists, such warning can come in the form of a simple color change.

Leica Microsystems and Visiopharm Announce Software Integration for Digital Pathology Image Analysis

Leica Microsystems, world-leading providers of Total Digital Pathology solutions, and Visiopharm the leading provider of Histoinformatics Solutions for Life-Sciences, today announce the completed integration of Leica’s SlidePath Digital Image Hub with Visiopharm’s Whole-Slide Informatics™ solutions for Digital Pathology.
Users can now take advantage of superior image capture and management from Leica Microsystems and excellent Whole Slide image analysis and Whole Slide Stereology from Visiopharm in a single system.

News-1007 

Source:
http://feeds.feedburner.com/DigitalPathologyBlog

Innovative Industry Leaders to Share Advanced Digital Pathology Knowledge

A distinguished field of 41 speakers will highlight the hot topics in the world of digital pathology at the 2011 Pathology Visions Conference. Telemedicine, neuropathology, and the image analysis of biomarkers are just some of the subjects experts will discuss at the 7th annual Digital Pathology Association Conference Oct. 30 – Nov. 2 in San Diego, CA.

(PRWEB) August 17, 2011

What are the hot topics in digital pathology today? Telemedicine, neuropathology, image analysis of biomarkers: These are just some of the topics experts will discuss at the 2011 Pathology Visions Conference. Forty-one distinguished experts will share their in-depth knowledge in the clinical, education and research areas at the 7th annual Digital Pathology Association Conference Oct. 30 – Nov. 2 in San Diego, CA.

“Access to sub-specialist pathologists using telepathology and image analysis of biomarkers are two of the strongest value propositions for why institutions adopt digital pathology,” said Dirk Soenksen, President of the Digital Pathology Association and Chair of the Pathology Visions Program Committee. “Attendees at this year’s conference will learn best practices for these and other applications of digital pathology, as well as how digital pathology can improve patient care and enable personalized medicine.”

In the clinical arena, Clayton Wiley, M.D., Ph.D., will discuss inter-institutional and interstate tele-neuropathology. Dr. Wiley will share his knowledge on telemedicine and its emersion as an efficient means of distributing professional medical expertise to geographically dispersed sites. He’ll also share his expertise on neuropathology and why it’s well-suited to utilize telepathology.

Tony Magliocco, M.D., will highlight the development of quantitative microscopy methods as prognostic and predictive cancer biomarkers. The digital pathology research expert will discuss three emerging analytical methods that hold promise for routine diagnostic pathology, including fractal analysis, analysis of DAB stained ki67 tissues with a focus on breast cancer, and the use of multiplex fluorescent imaging to study "functional tissue dynamics."

Early pathologists started laying the groundwork for the digital pathology industry nearly a century and a half ago.Dr. Clive Taylor, M.D.,D. Phil., will give the audience a history lesson about the journey from microscopy to whole slide images. Dr. Taylor’s insight into how the past has shaped our industry will give attendees a firmer grasp on the important role they will play in the future of digital pathology.

These three speakers offer just a sneak peek at a line-up filled with distinguished presenters. The Pathology Visions Conference will host 38 additional research, education and clinical experts. Click here for a complete list of the speakers and details of their presentations.

Conference attendees will also have the opportunity to earn up to 13 CME credits, take part in an FDA panel discussion, and participate in cutting-edge industry workshops. DPA white paper and scientific poster sessions, roundtable discussions, networking events, and dozens of exhibitor displays will round out the three day conference. Register now for the internationally-acclaimed conference.

The Pathology Visions Conference is also offering a special discounted rate for conference guests. For a reduced registration fee, your spouse or special guest can attend all meals and the Sunday evening welcome reception.

The mission of the Digital Pathology Association is to facilitate education and awareness of digital pathology applications in health care. Members will be encouraged to share best practices and promote the use of the technology among colleagues in order to demonstrate efficiencies, awareness, and its ultimate benefits to patient care.

Source:
http://feeds.feedburner.com/DigitalPathologyBlog

DigiPath Licenses Olympus Digital Pathology Patents

 

 

DigiPath follows course of several whole slide imaging device manufacturers and licenses Olympus patents.

HENDERSON, Nev. and CENTER VALLEY, Pa., USA, August 17, 2011 -- DigiPath, Inc®, a provider of affordable, innovative and reliable digital pathology solutions, and Olympus America Inc., a precision technology leader designing and delivering innovative solutions in life science imaging and other product areas, have entered into a nonexclusive worldwide agreement allowing DigiPath and its OEM partners to access an extensive portfolio of Olympus patents in the field of virtual microscopy and digital pathology. The patents involved in the licensing agreement cover methods, software and technology for creating, storing and delivering virtual microscopy images.

 

Virtual microscope slides enable professionals to review biopsies and other pathology images without handling traditional glass slides, and allow doctors to share high-resolution digital microscope images over telecommunication networks for second opinion consultation, tumor board review, and image archiving functions.

 

"Licensing these patented technologies and approaches to innovative new companies like DigiPath is very important to us," said Mr. Hidenao Tsuchiya, Vice President and General Manager of Olympus America Inc., Scientific Equipment Group. "Agreements like this help foster widespread digital imaging adoption where affordability and improving advanced patient care are vital."

 

"DigiPath is delighted to work with Olympus," said Eric Stoppenhagen, Chief Executive Officer for DigiPath.  "Our clients and OEM partners can be assured their investments in digital pathology are stable and secure."

 

About DigiPath, Inc.

DigiPath, Inc. provides the next generation of affordable, innovative, and reliable digital pathology solutions.  DigiPath's advisors bring over 60 years combined expertise in pioneering digital pathology, implementing over 500 installations at community pathology practices, hospitals, academic medical centers, reference laboratories, biopharma organizations, and life science research institutions worldwide.

 

About Olympus Scientific Equipment Group

Olympus America Scientific Equipment Group provides innovative microscope imaging solutions for researchers, doctors, clinicians and educators. Olympus microscope systems offer unsurpassed optics, superior construction and system versatility to meet the ever-changing needs of microscopists, paving the way for future advances in life science. Visit http://www.olympusamerica.com/microscopes.

 

About Olympus

Olympus is a precision technology leader, designing and delivering innovative solutions in its core business areas: Medical and Surgical Products, Life Science Imaging Systems, Industrial Measurement and Imaging Instruments and Cameras and Audio Products. Olympus works collaboratively with its customers and affiliates worldwide to leverage R&D investment in precision technology and manufacturing processes across diverse business lines.

 

These include:

  • Gastrointestinal endoscopes, accessories, and minimally invasive surgical products;
  • Advanced research, clinical and educational microscopes and research and educational digital imaging systems;
  • Industrial research, engineering, test, inspection and measuring instruments; and
  • Digital cameras and voice recorders.

 

Olympus serves the healthcare field with integrated product solutions and financial, educational and consulting services that help customers to efficiently, reliably and more easily achieve exceptional results. Olympus develops breakthrough technologies with revolutionary product design and functionality for the consumer and professional photography markets, and also is the leader in gastrointestinal endoscopy and clinical and educational microscopes.  For more information, visit http://www.olympusamerica.com.

 

Olympus is a registered trademark of Olympus Corporation, Olympus America Inc., and/or their affiliates in the U.S. and/or other countries.

Source:
http://feeds.feedburner.com/DigitalPathologyBlog

2nd International Definiens Symposium 2011

REGISTER NOW!

PROGRAM SPEAKERS - Top Notch Line Up!

After the great success and feedback from the Definiens Symposium 2010 in Madrid, Definiens is pleased to announce the International Definiens Symposium 2011. The venue will take place at the Moffitt Cancer Center in Tampa, Florida, October 17-18, 2011.  We invite you to join this event to hear about groundbreaking research, meet other users and share your ideas.

The annual Definiens Symposium is the premier forum for Definiens users and developers from around the world to present their latest research, techniques and workflows in life science image and data analysis. Participants come from research institutions, bio-pharmaceutical companies and the healthcare sector.


Venue:
H. Lee Moffitt Cancer Center and Research Institute, Vincent A. Stabile Research Building, 12902 Magnolia Drive, Tampa, FL 33612, USA

The 2011 Definiens Symposium will be an ideal opportunity to share the latest ideas in state-of-the-art image analysis and to meet international experts from the Definiens community.

REGISTER NOW!

Sessions will include:

  • Biomarker Development and Validation
  • Basic Research and Drug Discovery
  • Toxicity and Efficacy Studies
  • Clinical Diagnostics

A social networking event will take place in Tampa's latin quarter, Ybor City, on Monday evening. Transportation between the Symposium venue and the evening event will be arranged.

Source:
http://feeds.feedburner.com/DigitalPathologyBlog